123+ peptides, organized by what you want to improve.
Browse research-backed peptides by wellness goal. Clinical and diagnostic-only molecules are tucked behind a separate filter to keep the wellness library focused.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.
Body Protection Compound studied for gut and tissue support.
Copper peptide researched for skin regeneration and collagen support.
GHRH analog often paired with Ipamorelin for pulsatile support.
Selective GH secretagogue with a clean research profile.
Russian-origin peptide studied for focus and neuroprotection.
Anxiolytic-style peptide researched for stress modulation.
Mitochondrial-derived peptide studied for metabolic health.
Pineal peptide researched for telomere and circadian support.
Studied in immune modulation and resilience contexts.
Synthetic fragment of Thymosin Beta-4 studied for tissue and vascular repair.
Copper peptide formulation researched for follicle support.
Melanocortin agonist researched for sexual desire and arousal.
Melanocortin agonist researched for tanning response and libido.
Modified GH fragment researched for adipose tissue effects.
GHRH analog FDA-approved for HIV-associated visceral fat.
Shorter-acting GHRH analog used in clinical GH research.
Ghrelin-mimetic GH secretagogue with appetite effects.
Potent ghrelin-mimetic with cardiac research interest.
Orally bioavailable non-peptide ghrelin mimetic.
Tripeptide fragment of α-MSH researched for inflammation.
Tight junction regulator studied for celiac disease.
Delta Sleep-Inducing Peptide studied for sleep architecture and stress.
Mitochondrial-derived peptide studied for neuroprotection and metabolism.
Human cathelicidin peptide with antimicrobial and immune-modulating activity.
Topical octapeptide researched for expression-line softening.
Topical matrikine researched for collagen stimulation.
Synthetic GnRH used to stimulate LH/FSH and testicular function.
Upstream regulator of GnRH studied for reproductive endocrinology.
Cardiolipin-targeting peptide studied for mitochondrial dysfunction.
Small-molecule NNMT inhibitor researched for fat metabolism.
Triple GLP-1/GIP/glucagon agonist in late-stage obesity trials.
FDA-approved GLP-1 agonist for diabetes and obesity.
FDA-approved GLP-1/GIP dual agonist.
Ghrelin-mimetic GH secretagogue researched for appetite and recovery.
Long-acting IGF-1 analog studied for anabolic and recovery effects.
Myostatin-binding protein fragment researched for muscle growth.
Long-acting amylin analog studied alongside GLP-1 agonists.
GLP-1/glucagon dual agonist in late-stage obesity trials.
Neuropeptide studied for social bonding and stress modulation.
Porcine-derived peptide mixture researched in neurologic recovery.
Angiotensin IV analog researched for synaptogenesis.
Senolytic peptide researched for clearance of senescent cells.
Short peptide bioregulator researched for cognition and aging.
Thymic peptide complex researched for immune restoration in aging.
FDA-approved daily GLP-1 receptor agonist.
Dipeptide-derived nootropic researched for memory and neuroprotection.
Synthetic nootropic peptide researched for synaptic plasticity.
Concentrated neuropeptide fraction for cognitive support research.
Semax derivative with enhanced neurotrophic activity.
Investigational triple hormone receptor agonist for metabolic disease.
GLP-1/glucagon dual agonist in Phase 3 development.
Endogenous peptide researched for heart and metabolic function.
Counter-regulatory peptide of the renin-angiotensin system.
Neuropeptide researched for immune modulation and lung protection.
Selective MC1R agonist FDA-approved for erythropoietic protoporphyria.
Erythropoietin-derived peptide researched for neuropathy and tissue repair.
Stabilized salt form of BPC-157 with enhanced stability.
Dipeptide bioregulator for immune system modulation.
Tripeptide bioregulator researched for cartilage and joint support.
Tripeptide bioregulator researched for vascular health.
Acetylated form of Epitalon with enhanced bioavailability.
Oral formulation of GHK-Cu for systemic regenerative research.
GnRH agonist used for prostate cancer, endometriosis, and precocious puberty.
GnRH agonist implant for hormone-sensitive cancers.
GnRH antagonist providing immediate testosterone suppression in prostate cancer.
First-in-class GLP-1 receptor agonist for type 2 diabetes.
Once-weekly GLP-1 agonist with cardiovascular benefit.
Short-acting GLP-1 agonist focused on postprandial glucose.
Amylin analog adjunct to mealtime insulin.
29-amino-acid peptide hormone for severe hypoglycemia.
Melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women.
Long-acting basal insulin analog for type 1 and type 2 diabetes.
Rapid-acting mealtime insulin analog.
Rapid-acting mealtime insulin analog.
Ultra-long-acting basal insulin with >42-hour duration.
Synthetic random peptide copolymer for relapsing multiple sclerosis.
GnRH agonist implant for central precocious puberty and prostate cancer.
Intranasal GnRH agonist for endometriosis and central precocious puberty.
Recombinant human IGF-1 for severe primary IGF-1 deficiency.
Long-acting pegylated growth hormone, once-weekly.
Once-weekly growth hormone analog for adults and children with GHD.